收藏切换
Long-acting C-type natriuretic peptide prodrug Navepegritide, a new approveddrug for the treatment of achondroplasia
收藏切换
PDF
Yan LI1, Xin HE2, Shuang HU2
Chinese Journal of Clinical Pharmacology | 2026, 42(10) : 1457 - 1461
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(10): 1457-1461
New Drugs Introduction
Long-acting C-type natriuretic peptide prodrug Navepegritide, a new approveddrug for the treatment of achondroplasia
Full
Yan LI1, Xin HE2, Shuang HU2
Affiliations
  • 1.Department of Pharmacy, Children Hospital and Maternal and Child Hospital of Shanxi Province, Taiyuan 030013, Shanxi Province, China
  • 2.Department of Pharmacy, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing 210004, Jiangsu Province, China
Published: 2026-05-28 doi: 10.13699/j.cnki.1001-6821.2026.10.017
Outline
收藏切换

Achondroplasia (ACH) is the most common hereditary short limb dwarfism, caused by functional acquired mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. In recent years, significant breakthroughs have been made in precision therapy targeting downstream pathways of FGFR3. Navepegritide (product name: YUVIWEL) is a long-acting C-type natriuretic peptide (CNP) prodrug that uses transient conjugation (TransCon) technology to couple CNP to PEG carrier molecules through a cleavable linker, achieving weekly subcutaneous administration. It was approved by the US Food and Drug Administration (FDA) in February 2026 to promote linear growth in children aged 2 years and above with non-closed epiphyseal plates and cartilage dysplasia. This article introduces the pharmacological properties, key clinical trial evidence, safety features, and clinical value of navepegritide, providing reference for clinical medication.

achondroplasia  /  Navepegritide  /  TransCon CNP  /  YUVIWEL
Yan LI, Xin HE, Shuang HU. Long-acting C-type natriuretic peptide prodrug Navepegritide, a new approveddrug for the treatment of achondroplasia[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (10) : 1457 -1461 . DOI: 10.13699/j.cnki.1001-6821.2026.10.017
Year 2026 volume 42 Issue 10
PDF
156
27
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.10.017
  • Receive Date:2026-05-01
  • Online Date:2026-08-06
  • Published:2026-05-28
Article Data
Affiliations
History
  • Received:2026-05-01
Affiliations
    1.Department of Pharmacy, Children Hospital and Maternal and Child Hospital of Shanxi Province, Taiyuan 030013, Shanxi Province, China
    2.Department of Pharmacy, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing 210004, Jiangsu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.10.017
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT